The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers, employers and government health programs who cover it in 2025. In this photo is a ...
Hosted on MSN
Bringing MTS bus drivers in-house would mean higher costs, more reliable service, study finds
A proposal to bring all local public bus service in-house would sharply increase costs compared with continuing to outsource, but the change would likely make buses more reliable and efficient, a new ...
NPR's series Cost of Living: The Price We Pay is examining what's driving price increases and how people are coping after years of stubborn inflation. How are higher prices changing the way you live?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results